Skip to search formSkip to main contentSkip to account menu

adriamycin-14-valerate

National Institutes of Health

Related topics

Related topics

3 relations

Narrower (1)

AD 48

Broader (1)

Doxorubicin
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1993
1993
N-benzyladriamycin-14-valerate (AD 198)-resistant cells exhibit highly selective cross-resistance to other anthracyclines that circumvent multidrug resistance.
N-Benzyladriamycin-14-valerate (AD 198)-resistant murine J774.2 macrophage-like cells (A300) exhibited a novel mechanism of… 
1992
1992
N-benzyladriamycin-14-valerate and drug resistance: correlation of anthracycline structural modification with intracellular accumulation and distribution in multidrug resistant cells.
N-Benzyladriamycin-14-valerate (AD 198) is a highly hydrophobic analogue of Adriamycin (ADR) which can circumvent multidrug… 
1989
1989
Interaction of N-alkylanthracyclines with lipid bilayers: correlations between partition coefficients, lipid phase distributions and thermotropic behavior.
1985
1985
Molecular level studies with anthracyclines.
There is steadily growing interest in the characterization of chemotherapeutic agents at the molecular level. Such… 
1980
1980
Pharmacologic studies with radiolabeled N-trifluoroacetyladriamycin-14-valerate (AD 32)
SummaryIn connection with pharmacologic studies with AD 32, isotopically-labeled drug prepared from 1-[14C]-trifluoroacetic… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)